Gerald L. Ray & Associates’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Gerald L. Ray & Associates's ABBV Position: Q3 2017 in Review
Gerald L. Ray & Associates reduced its AbbVie (ABBV) stake by 1% in Q3 2017, selling an estimated $22.8K and leaving 29,427 shares worth $2.62M. The position accounts for 0.33% of the portfolio, ranked #75.
Gerald L. Ray & Associates first reported a position in ABBV in Q2 2013 and has held it in 18 quarters since. 1,797 funds tracked by Wall St. Rank hold ABBV as of Q3 2017.
- Gerald L. Ray & Associates held 29,427 shares of AbbVie worth $2.62M as of Q3 2017.
- Gerald L. Ray & Associates sold 300 AbbVie shares in Q3 2017, an estimated $22.8K.
- AbbVie made up 0.33% of Gerald L. Ray & Associates's portfolio in Q3 2017, its #75 holding.
- Gerald L. Ray & Associates first reported a position in AbbVie in Q2 2013 and has held it in 18 quarters since.
- 1,797 funds tracked by Wall St. Rank held AbbVie as of Q3 2017.
Based on Gerald L. Ray & Associates's 13F filing for Q3 2017, filed 31 Oct 2017.